BIO To Senate Health Panel: More Exclusivity Needed To Spur Innovation

The Biotechnology Industry Organization is (BIO) encouraging Senate health chair Lamar Alexander (R-TN) to look at extending drug exclusivity for manufacturers as a way to spur innovation and scientific advancement in drug development as he works with ranking Democrat Patty Murray (WA) to draft parallel and complementary legislation to the House Energy and Commerce Committee's 21st Century Cures initiative. A discussion draft of the House Cures initiative proposes increasing exclusivity for a number of drug classes, including 15 years for...